Document Detail


Fertility preservation in children and adolescents with cancer.
MedLine Citation:
PMID:  21311429     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
With excellent survival rates for individuals diagnosed with cancer during childhood or adolescence an awareness of quality of life, including fertility preservation is essential. Chemotherapeutic regimens that include alkylating agents and radiation treatments directed at the gonads or pituitary, including total body irradiation are particularly gonadotoxic. Assessment of potential for gonadotoxicity and appropriateness of fertility preservation techniques prior to the start of cancer directed therapies in every individual pediatric patient is crucial for limiting this late effect of therapy. Sperm banking for postpubertal males prior to the initiation of gonadotoxic therapy should be considered standard of care. Postpubertal females receiving highly gonadotoxic therapy that places them at risk of acute ovarian failure should consider embryo or oocyte cryopreservation prior to the initiation of therapy. Oocyte cryopreservation, as well as cryopreservation of gonadal tissue, whether ovarian or testicular, remain experimental and as such should be offered as part of a research protocol. Females who receive treatment that deplete their ovarian reserve should be evaluated for the development of premature menopause following their treatment. Embryo or oocyte cryopreservation post therapy may offer females at risk of premature menopause the opportunity to preserve their reproductive window. Further research clarifying gonadotoxicity of contemporary treatment regimens and improving interventions to preserve fertility are necessary to prevent infertility as a long term adverse effect of cancer treatment. The establishment of programs that streamline access to current fertility preservation techniques will assist in ensuring that all eligible patients can avail themselves of current options.
Authors:
J Levine
Related Documents :
17317819 - Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin b1.
12150449 - C-myc oncogene amplification in ductal carcinoma in situ of the breast.
16491599 - Measurement of estrogen receptor status by immunocytochemistry in paraffin wax sections.
16131469 - Is anthracycline-based chemotherapy alone adequate for young women with estrogen recept...
21467709 - Malignant pleural effusion from lung adenocarcinoma treated by gefitinib.
15339969 - Probabilities of death from breast cancer and other causes among female breast cancer p...
371789 - Tube leukocyte adherence inhibition (lai) assay in gastrointestinal (git) cancer.
15151719 - In-vitro maturation of germinal-vesicle oocytes and cryopreservation in metaphase i/ii:...
21224849 - Tgf-β regulates isoform switching of fgf receptors and epithelial-mesenchymal transition.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Minerva pediatrica     Volume:  63     ISSN:  0026-4946     ISO Abbreviation:  Minerva Pediatr.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400740     Medline TA:  Minerva Pediatr     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  49-59     Citation Subset:  IM    
Affiliation:
Division of Oncology, Department of Pediatrics, Oncology, Pediatrics, Columbia University Medical Center, New York, NY, USA - Jl175@columbia.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New adolescent polycystic ovary syndrome perspectives.
Next Document:  Complete clinical recovery of a central pontine and extrapontine myelinolysis delayed onset in a chi...